CDMRP Congressional Briefing: Prostate & Kidney Cancer Research Programs

By Policy and Advocacy Brief posted 03-18-2021 12:18


Please enjoy this briefing presented by the American Urological Association (AUA), KidneyCAN, and ZERO: The End of Prostate Cancer, on the important research conducted through the Kidney Cancer Research Program (KCRP) and Prostate Cancer Research Program (PCRP), which are part of the Congressionally Directed Medical Research Programs (CDMRP).

The CDMRP originated in 1992 via a Congressional appropriation through the Department of Defense to foster novel approaches to biomedical research. These programs focus on military medical research, cancer research and other disease- and injury-specific research. All the programs managed by CDMRP share the common goal of filling gaps in research by funding high impact, high risk and high gains projects that lead to improvements in patient care, breakthrough technologies and resources for clinical benefit.

During the program, you will hear from the following panel of experts:

  • AUA President, Dr. Scott Swanson
  • US House Representative Rosa DeLauro (D-CT-03), Chair of the House Appropriations Committee and Chair of the Subcommittee on Labor, Health and Human Services, Education, and Related Agencies 
  • AUA Director of Research, Dr. Carolyn Best
  • Mr. Anthony Minter, prostate cancer patient and Consumer Reviewer for PCRP
  • Dr. Hyung Kim, director of the Cedars-Sinai Academic Urology Program, associate director of Surgical Research in the Samuel Oschin Comprehensive Cancer Center, and KCRP peer reviewer
  • Dr. Brandon Manley, genitourinary oncologist at Moffitt Cancer Center, and recipient of KCRP awards.

The AUA, KidneyCAN, and ZERO extend a special thanks to the Prostate Cancer Impact Alliance, the Kidney Cancer Impact Alliance, and all of the panelists.